Anson Funds Management’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Anson Funds Management’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,000	Closed	-$153K	–	219
2023 Q1	$153K	Hold	15,000	–	–	0.03%	162
2022 Q4	$151K	Hold	15,000	–	–	0.02%	206
2022 Q3	$148K	Hold	15,000	–	–	0.02%	259
2022 Q2	$146K	Hold	15,000	–	–	0.01%	288
2022 Q1	$146K	Hold	15,000	–	–	0.01%	305
2021 Q4	$145K	Hold	15,000	–	–	0.01%	322
2021 Q3	$147K	Buy	+15,000	New	+$19.5K	0.01%	294

Anson Funds Management's ORIAW Position: Q2 2023 in Review

Anson Funds Management sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 15,000 shares — an estimated $153K sold.

Anson Funds Management first reported a position in ORIAW in Q3 2021 and held it in 7 quarters. The position peaked at $153K in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Anson Funds Management reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Anson Funds Management sold 15,000 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $153K.
Anson Funds Management first reported a position in Orion Biotech Opportunities Corp. Warrant in Q3 2021 and held it in 7 quarters.
Anson Funds Management's Orion Biotech Opportunities Corp. Warrant position peaked at $153K in Q1 2023.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Anson Funds Management's 13F filing for Q2 2023, filed 14 Aug 2023.